Kutatási jelek – Signal Engine

• Treatment of Diffuse Large B‑cell Lymphoma Progressing or Relapsing after Chimeric Antigen Receptor T‑cell Therapy — Diffuse large B-cell lymphoma
• Efficacy and safety of anti‑PD‑1/PD‑L1 antibodies in patients with relapsed refractory diffuse large B‑cell lymphoma: A meta‑analysis — Diffuse large B-cell lymphoma
• First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn — Head and neck squamous cell carcinoma
• Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase-Targeted Approaches — Mantle cell lymphoma
• Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry — Multiple myeloma
• Transforming mantle cell lymphoma: the journey across eras — Mantle cell lymphoma
• Letrozole, abemaciclib and metformin in endometrial cancer — Endometrial cancer
• HDACi induces apoptosis of osteosarcoma cells by inhibiting the MAPK pathway — NSCLC
• Immunotherapy Utilization Outcomes in Distantly Metastatic Head and Neck Squamous Cell Carcinoma — Head and neck squamous cell carcinoma
• Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma — Nasopharyngeal carcinoma
• Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia — Waldenstrom macroglobulinemia
• Amino acid metabolic reprogramming: future prospects for cholangiocarcinoma therapy — Cholangiocarcinoma
• Long‑Term Durability of Active Surveillance of Small, Low‑Risk Papillary Thyroid Cancer — Thyroid cancer
• Intrinsic cellular resistance to BCR::ABL1 inhibitors — Chronic myeloid leukemia
• The potential of real-time dynamic disease monitoring with circulating tumor DNA: important lessons from Epstein-Barr virus-related nasopharyngeal carcinoma — Nasopharyngeal carcinoma
• A Case of Waldenstrom's Macroglobulinemia Presenting as Worsening Neuropathy — Waldenstrom macroglobulinemia
• Targeted inactivation of EWSR1::FLI1 gene in Ewing sarcoma via CRISPR/Cas9 driven by an Ewing-specific GGAA promoter — Ewing sarcoma
• Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial — Acute myeloid leukemia
• Complete remission of a high-risk, locally advanced cervical cancer with para-aortic lymph node metastases treated with first-line tislelizumab plus bevacizumab combined with chemotherapy followed by radiotherapy with maintenance therapy: a case report — Cervical cancer
• Real-world first-line serplulimab therapy for advanced esophageal cancer: effectiveness, safety, and clinical implications — Esophageal cancer